Walter Wigger-Alberti, M.D.
CEO and Clinical Advisor Dermatology
A dermatologist by training, Dr. Wigger-Alberti obtained his M.D. from the University of Kiel, Germany. Following residencies in dermatology in Westerland, Germany and the University Hospital in Zurich, Switzerland, he assumed a position in 1997 as attending physician and Head of the Skin Research Laboratory in the Department of Dermatology and Dermatological Allergology at the University of Jena, Germany. In 2001 Dr. Wigger-Alberti joined a dermatological CRO as Director of Clinical Research where he remained until joining bioskin in April 2009. Dr. Wigger-Alberti also holds a position as lecturer in the Department of Dermatology at the University of Osnabrück.
Yi-Ling von Mackensen, M.D.
Dr. von Mackensen is responsible for medical oversight and dermatological consulting for the trials coordinated by bioskin and leads a team of dermatologists and physicians within bioskin’s own Research Center. After secondary studies in Canada, Dr. von Mackensen studied medicine and completed her M.D. and doctorate at the University of Kiel, Germany. She continued specialization in Kiel, St. Peter-Ording and Hamburg before being certified as a dermatologist and allergologist, gaining experience in clinical trials during this time. She has been at bioskin since 2011.
Andrea Schmidt, Ph.D.
Chief Operating Officer
Dr. Schmidt, at bioskin since 1999, oversees the clinical operations, which includes clinical trial management of single and multi-center trials in Europe, monitoring, data management, statistics and medical writing as well as the proposal and contract management. Dr. Schmidt holds a Ph.D. in Pharmaceutical Biology and an M.S. in Microbiology both from the University of Hamburg, and gained experience in the fields of essential oils, disinfectants and microbiological stability testing during that time.
Andrej Pischkow, M.A.
Director Quality Management
Andrej Pischkow began his career in Data Management at Astra Zeneca in 2001. In October 2005 he joined bioskin as a Clinical Monitor (CRA) and was Lead Monitor from August 2008 to May 2009 when he moved into his current position as Director of Quality Management. Mr. Pischkow holds an M.A. in German and Slavic philology from the Ernst-Moritz-Arndt-University in Greifswald, Germany.